Skip to main content

Table 5 Triglycerides (mg/dL) in the 19 patients who completed the study

From: LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia

  Argicolina Normolip Argicolina/Normolip rate
At start of treatment 104.2 97.6 106.8 (96.3118.4)
At end of treatment 86.9* 93.1 93.3 (81.0107.4)
Final / Initial % 83.4 (72.0 96.5) 95.4 (85.9106.0) 87.4 (73.3104.1)
  1. Data are expressed as geometric mean (95% CI) and analyzed by Student’s t test for paired data (end vs. start of treatment) after logarithmic transformation, * p < 0.05